TSHA logo
Taysha Gene Therapies, Inc.(TSHA)
Last print unknown agoAbout this dataData status
$3.94▲0.32 (8.84%)Stale · unknown oldEarnings · Nov 3

TSHA SBC to Revenue

331.29%TTM

Retrieved:

TSHA FY SBC/Revenue%
TSHA FY SBC/Revenue807.68%-86.54%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

TSHA sbc to revenue history

Stock-based compensation as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Taysha Gene Therapies Inc SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
136.0688%
157.2423%
51.1617%
721.1431%
0%
0%
0%

Compare sbc to revenue

All TSHA financial metrics · TSHA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.